Orchid Biosciences Inc (ORCH)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-TESTING LABORATORIES
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

4390 US ROUTE ONE PRINCETON, NJ 08540

Engages in the development and delivery of genetic testing, or genotyping, services that generate information related to disease susceptibility and genetic uniqueness, or the genetic variability that distinguishes one organi® from another. Name changed to Orchid Cellmark Inc. June 15, 2005.

Are you looking for this stock instead?

View SEC Filings from ORCH instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ORCH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORCH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THOMAS WILLIAM JOHN VP & GENERAL COUNSEL

  • Officer
No longer subject to file 2011-12-15 0

SMITH JAMES FRANCIS VICE PRESIDENT AND CFO

  • Officer
No longer subject to file 2011-12-15 0

BOLOGNA THOMAS A PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2011-12-15 0

LABORATORY CORP OF AMERICA HOLDINGS

  • 10% Owner
34,455,961 2011-12-15 0

WILLIAMS NICOLE

  • Director
No longer subject to file 2011-12-15 0

DALZIEL BRUCE D

  • Director
No longer subject to file 2011-12-15 0

EBERTS F SAMUEL III PRESIDENT AND SECRETARY

  • Officer
  • Director
0 2011-12-09 0

HAYES WILLIAM B EVP AND TREASURER

  • Officer
  • Director
0 2011-12-09 0

BOYLE JAMES T. JR.

  • Director
0 2011-12-09 0

WALTON ANDREW SCOTT

  • Director
0 2011-12-09 0

VAN DER VAART SANDRA D ASSISTANT SECRETARY

  • Officer
  • Director
0 2011-12-09 0

BOSCHWITZ JEFFREY S. VP, NORTH AMERICA MKT & SALES

  • Officer
0 2010-05-26 0

DAVIS EUGENE I

  • SEE EXPLANATION OF RESPONSES
0 2010-03-31 0

LOREN STEFAN

  • SEE EXPLANATION OF RESPONSES
2,000 2010-03-31 0

HART JAMES M.

  • Director
0 2010-01-01 0

ACCIPITER CAPITAL MANAGEMENT, LLC

CANDENS CAPITAL LLC

HOFFMAN GABE

ACCIPITER LIFE SCIENCES FUND LP

ACCIPITER LIFE SCIENCES FUND II L P

ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
3,923,498 2009-12-23 0

HECHT SIDNEY M

  • Director
No longer subject to file 2009-10-07 0

NOONAN KENNETH D

  • Director
No longer subject to file 2009-10-07 0

BEERY JAMES CHAIRMAN OF THE BOARD

  • Officer
  • Director
No longer subject to file 2009-10-07 0

BRIDGER MANAGEMENT LLC

MIGNONE ROBERTO

BRIDGER CAPITAL LLC

SWIFTCURRENT PARTNERS

SWIFTCURRENT OFFSHORE LTD

  • 10% Owner
3,962,179 2008-12-12 0

ACCIPITER CAPITAL MANAGEMENT, LLC

CANDENS CAPITAL LLC

HOFFMAN GABE

ACCIPITER LIFE SCIENCES FUND LP

ACCIPITER LIFE SCIENCES FUND II L P

ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD

ACCIPITER LIFE SCIENCES FUND II OFFSHORE LTD

ACCIPITER LIFE SCIENCES FUND II QP L P

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
4,397,772 2008-11-12 0

POSTE GEORGE

  • Director
0 2008-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments